Author
Listed:
- Mark R. Woodford
(SUNY Upstate Medical University
Cancer Research Institute, SUNY Upstate Medical University)
- Diana M. Dunn
(SUNY Upstate Medical University
Cancer Research Institute, SUNY Upstate Medical University
SUNY Upstate Medical University)
- Adam R. Blanden
(Cancer Research Institute, SUNY Upstate Medical University
SUNY Upstate Medical University)
- Dante Capriotti
(SUNY Upstate Medical University
Cancer Research Institute, SUNY Upstate Medical University)
- David Loiselle
(Duke University Medical Center)
- Chrisostomos Prodromou
(Genome Damage and Stability Centre, University of Sussex)
- Barry Panaretou
(Institute of Pharmaceutical Science, King’s College London)
- Philip F. Hughes
(Duke University Medical Center)
- Aaron Smith
(Duke University Medical Center)
- Wendi Ackerman
(Health Sciences Library, SUNY Upstate Medical University)
- Timothy A. Haystead
(Duke University Medical Center)
- Stewart N. Loh
(Cancer Research Institute, SUNY Upstate Medical University
SUNY Upstate Medical University)
- Dimitra Bourboulia
(SUNY Upstate Medical University
Cancer Research Institute, SUNY Upstate Medical University
SUNY Upstate Medical University)
- Laura S. Schmidt
(Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research
Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute)
- W. Marston Linehan
(Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute)
- Gennady Bratslavsky
(SUNY Upstate Medical University
Cancer Research Institute, SUNY Upstate Medical University)
- Mehdi Mollapour
(SUNY Upstate Medical University
Cancer Research Institute, SUNY Upstate Medical University
SUNY Upstate Medical University)
Abstract
Heat shock protein-90 (Hsp90) is an essential molecular chaperone in eukaryotes involved in maintaining the stability and activity of numerous signalling proteins, also known as clients. Hsp90 ATPase activity is essential for its chaperone function and it is regulated by co-chaperones. Here we show that the tumour suppressor FLCN is an Hsp90 client protein and its binding partners FNIP1/FNIP2 function as co-chaperones. FNIPs decelerate the chaperone cycle, facilitating FLCN interaction with Hsp90, consequently ensuring FLCN stability. FNIPs compete with the activating co-chaperone Aha1 for binding to Hsp90, thereby providing a reciprocal regulatory mechanism for chaperoning of client proteins. Lastly, downregulation of FNIPs desensitizes cancer cells to Hsp90 inhibitors, whereas FNIPs overexpression in renal tumours compared with adjacent normal tissues correlates with enhanced binding of Hsp90 to its inhibitors. Our findings suggest that FNIPs expression can potentially serve as a predictive indicator of tumour response to Hsp90 inhibitors.
Suggested Citation
Mark R. Woodford & Diana M. Dunn & Adam R. Blanden & Dante Capriotti & David Loiselle & Chrisostomos Prodromou & Barry Panaretou & Philip F. Hughes & Aaron Smith & Wendi Ackerman & Timothy A. Haystead, 2016.
"The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding,"
Nature Communications, Nature, vol. 7(1), pages 1-15, November.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12037
DOI: 10.1038/ncomms12037
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12037. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.